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Objective: Deﬁ  ning an optimal staging strategy requires an evaluation of the effectiveness 
and costs of diagnostic tests and may include the burden of these tests for patients. This study 
evaluated the burden of cervical ultrasonography (US), endoscopic ultrasonography (EUS), 
computed tomography (CT) and positron emission tomography (PET) in patients with esopha-
geal carcinoma (EC).
Methods: Consenting consecutive patients underwent a standard preoperative work-up. Burden 
of testing was evaluated with a self-report questionnaire addressing anxiety, embarrassment, 
and discomfort, each measured on a 1(none) to 5 (extreme) point-scale. An overall burden 
score was calculated by summing the three item scores. In addition, patients were asked to 
rank the four tests from least to most inconvenient. Statistical analysis was performed with 
nonparametric tests.
Results: 82 patients (67  , 15  ; mean age 64.3 yrs) participated. For most tests and most 
dimensions of burden, the large majority of subjects was in categories 1 and 2.With respect 
to anxiety, the rank order (from highest burden to lowest burden) was EUS, US, PET, and CT 
(average scores 1.7, 1.5, 1.4, and 1.2, respectively). For embarrassment, the rank order was EUS, 
PET, US, and CT (1.9, 1.5, 1.4, and 1.3 respectively). For discomfort, the rank order was EUS, 
PET, US and CT (2.0, 1.6, 1.4, and 1.2, respectively). And for total burden, the rank order was 
EUS, PET, US and CT (5.6, 4.6, 4.2, and 3.7). PET was ranked as least inconvenient by 35% 
of patients and as most inconvenient by 16% compared with the other tests.
Conclusion: Signiﬁ  cant but small differences were observed in patient burden for imaging 
tests to evaluate EC. The perceived burden of PET was lower than that of EUS, but higher than 
the burden of CT. However absolute values were low for all tests and therefore patient burden 
will not be a key feature for the construction of an optimal staging algorithm for EC.
Keywords: esophageal carcinoma, perceived burden, cervical ultrasonography, endoscopic 
ultrasonograhy, computed tomography, positron emission tomography
Introduction
The incidence of adenocarcinomas of the esophagus or gastroesophageal junction (GEJ) 
is rising (Falk 2002; Jenkins et al 2002; Wijnhoven et al 2001). Surgical resection is 
currently the best curative treatment in patients without distant metastases and/or locally 
irresectable tumor growth (Daly et al 2000). Conventional imaging techniques are 
employed to select only patients with potentially curable disease for esophagectomy. 
Currently, the most common conventional modalities for staging of esophageal cancer 
(EC) are cervical ultrasonography (US) with ﬁ  ne needle aspiration (FNA), endoscopic 
ultrasonography (EUS) with FNA, and computed tomography (CT).
Despite these efforts preoperatively, distant metastatic spread is encountered 
during operation in 10%–20% of patients (Sariego et al 1993; Clements et al 2004; 
van Westreenen et al 2005). During the last decade, positron emission tomography 
(PET) using 18F- Fluorodeoxyglucose has been introduced as a noninvasive method Patient Preferences and Adherence 2008:2 158
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for staging esophageal cancer, especially for the detection 
of distant lymphatic and hematogenous metastases (Block 
et al 1997; Flanagan et al 1997; Luketich et al 1997; Flamen 
et al 2000; van Westreenen 2004). Selection of patients for 
esophageal cancer resection with curative intent could be 
improved by the implementation of PET, which has been 
suggested by former studies (Flamen et al 2000).
The exact role of PET in the staging pathway of 
esophageal cancer is not clear yet. The pathway will be 
predominantly based on maximizing diagnostic accuracy at 
acceptable costs. If differences in the accuracy of the vari-
ous tests are small, or, when added, the additional value of 
a procedure is limited, patient burden of the various tests 
may become an important feature for the construction of an 
optimal staging algorithm.
We designed a study to evaluate and compare the patient 
burden of cervical ultrasonography (US), endoscopic ultra-
sonograhy (EUS), computed tomography (CT) and positron 
emission tomograhy (PET) in the work-up of patients with 
esophageal cancer.
Patients and methods
Between November 2003 and July 2004, a consecutive group 
of 82 consenting patients with esophageal carcinoma visited 
one of two participating medical centers (Academic Medical 
Center (AMC), Amsterdam and University Medical Center 
Groningen (UMCG), the Netherlands) and were asked about 
the impact of the diagnostic procedures (AMC: 51, UMCG: 
31 patients). The medical ethics committees of both hospitals 
approved this study.
Patients who were in sufﬁ  ciently good condition for 
major surgery, with histologically conﬁ  rmed potentially 
curable esophageal or GEJ carcinoma as estimated by 
history and physical examination underwent a cervical 
US with or without FNA, EUS with or without FNA, and 
multidetector CT of neck, chest, and abdomen as part 
of routine work-up. These patients were also asked to 
undergo PET.
Staging procedures
All patients underwent the four test procedures: US ± FNA, 
EUS ± FNA, CT, and PET (see Table 1). All tests were per-
formed within two weeks; the order was determined based 
upon waiting times and availability. All diagnostic tests 
were performed according to a standard procedure that had 
been established during joint meetings of the research group 
members of the two participating hospitals. Patients received 
a written information sheet prior to all tests.
Cervical ultrasonography
Cervical US with cytological biopsy of suspicious lesions was 
performed using either a 15.2 MHz or 7.5 MHz linear array 
transducer. Round echogenic lymph nodes with a diameter 
of more than 5 mm were considered suspected and were 
investigated by cytology.
Ultrasound-guided FNA was performed for cytologi-
cal analysis using a standard 21-gauge intravenous needle 
in 14 of the 82 (17%) patients. Estimated room-time was 
15 minutes.
Endoscopic ultrasonography
A radial scanner (GF-UM130 or GF-UM160; 5–20 MHz, 
Olympus Medical Systems, Tokyo, Japan) was used for the 
performance of EUS. EUS-guided FNA was obtained by a 
separate linear array echo-endoscope (FF-UC140P, Olympus 
Medical Systems, Tokyo, Japan). FNA was performed with 
a 22-gauge needle (Echotip, Wilson-Cook Medical Inc., 
Winston Salem, USA) in 8 of the 82 (10%) of the patients. 
In 7 patients (8%) a stenotic tumor did not allow the standard 
echo-endoscope to pass, and a small-caliber probe (MH-908, 
7.5 MHz, Olympus Medical Systems, Tokyo, Japan) was 
used in an attempt to traverse the tumor.
EUS was performed with conscious sedation using 
2.5–10 mg midazolam intravenously with the patient in a 
left decubitus position. The duration of the procedure was 
about 30 min. After the procedure, the patient was observed 
for at least 120 min.
Table 1 Characteristics of the four test procedures
Procedure Fasting IV  puncture Sedation Pharmaceutical FNA Duration
           (min.)
US No  No  No  None  Yes  15
EUS Yes  Yes  Yes  None  Yes  150
CT No  Yes  No  i.v.  contrast  No  20
PET Yes  Yes  No  18F-FDG No  150
Abbreviations: US, cervical ultrasonography; CT, computed tomography; EUS, endoscopic ultrasonography; PET, positron emission tomography; IV, intravenous; 18F-FDG, 
ﬂ  uoro-deoxyglucose; FNA, ﬁ  ne needle aspiration (prevalence see results section in text).Patient Preferences and Adherence 2008:2 159
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Computed tomography
Multidetector CT was performed with a 4-ring or 16-ring 
CT scanner (Philips MX 8000, Best, The Netherlands, 
-AMC or Somatom Sensation, Siemens, Erlangen, Germany, 
-UMCG). Scans were obtained of the lower neck, chest, and 
upper abdomen including the liver. The patient had to drink 
500 ml of oral contrast directly before the CT-examination. 
The CT-examination comprised two consecutively per-
formed scans during breath hold after an intravenous 
injection of contrast medium (120 ml low osmolar contrast 
medium at 3.5 ml/s). First scan after a delay of 20–25 sec-
onds after start of contrast injection included the chest and 
supraclavicular region. After a delay of 90 seconds after start 
of contrast injection a second spiral scan was performed of 
the upper abdomen, at least including the liver and celiac 
region. The room-time of the CT-examination was approxi-
mately 20 minutes.
Positron emission tomography
The studies were performed using an ECAT EXACT 
HR+ (Siemens/CTI Inc., Knoxville, TN, USA). After an 
overnight or 6 hr fast period, 370–555 MBq was injected 
intravenously for 2D acquisitions (lower limit for patients 
85 kg, upper limits for patients 85 kg). Patients were 
prehydrated with 500–1500 ml water. Interval between FDG 
injection and image acquisition was 60–90 min, during this 
time period bedrest was prescribed for the ﬁ  rst half-hour. 
Scans were obtained from the midfemoral region up to the 
skull. Emission scan-duration was 5 min per bed position, 
transmission imaging (always-performed) 3 min. Duration 
of the scan was approximately 60 minutes. Duration of the 
entire procedure was 2 ½ hours.
Test questionnaire
Two weeks after having ﬁ  nished all tests, patients were 
requested to complete a self-report questionnaire. The 
questionnaire consisted of three modules. First, a standard 
formatted Likert scoring module (Likert 1932). was used 
with two items addressing embarrassment and discomfort 
for each of the four staging modalities. The two items have 
previously been used in a study of the acceptance of computer 
tomographic colonoscopy by patients (van Gelder et al 2004). 
We added anxiety as a third item (Katz et al 1994; Melendez 
and McCrank 1993; MacKenzie et al 1995). Responses 
were scored on a ﬁ  ve-point anchored scale with 1 indicating 
‘none’, 2 indicating ‘ little’, 3 indicating ‘quite’, 4 indicating 
‘very’, and 5 indicating ‘very much’. An overall burden score 
was calculated as the sum of the three items scores.
In addition, a comparative assessment item was used, 
inviting patients to rank the different tests from least to most 
inconvenient.
Statistical analyses
The nonparametric Friedman test for related samples was 
used to compare the burden and ranking of the different tests. 
The Mann-Whitney U test was used to test for differences 
between groups of patients with respect to sum of burden 
scores. Subgroup analyses were performed based on US 
and/or EUS with or without FNA.
Results
During the study period 82 patients were enrolled in this study 
(67 male; 15 female). Their mean age was 64.3 (SD ± 8.3) 
years. After conventional work-up 5 patients had a T1 tumor, 
10 patients a T2 tumor, 63 patients a T3 tumor, and 4 patients 
had a T4 tumor.
All test data were available and could be analyzed. For 
most tests and most dimensions of burden, the large major-
ity of subjects was in categories 1 and 2 (Table 2). Patients 
scored more often 4 (very) or 5 (very much) for EUS 
regarding embarrassment and discomfort (both 7 patients) in 
comparison with US (both 3 patients), CT (1 and no patient 
respectively) and PET (both 3 patients). Regarding anxiety, 
respectively 5 and 6 patients scored 4 or 5 on EUS and PET, 
while only 2 patients scored 4 or 5 on US and CT.
The averages scores were between 1.0 and 2.0 for all 
items (see Table 2 and Figure 1).
With respect to anxiety, the rank order (from highest to low-
est scores) was: EUS (1.7, SD 1.0), US (1.5, SD 0.8, P = 0.01), 
PET (1.4, SD 1.0, P = 0.03), CT (1.2, SD 0.8 P = 0.00). For 
embarrassment, the rank order was: EUS (1.9, SD 1.0), PET 
(1.5, SD 0.9), US (1.4, SD 0.8), CT (1.3, SD 0.6). For dis-
comfort, the rank order was: EUS (2.0, SD 1.0), PET (1.6, SD 
0.8), US 1.4 (SD 0.7), and CT (1.2, SD 0.4). For total burden, 
CT had signiﬁ  cantly the lowest average score: 3.7 (SD 1.3, 
range 3–10) (all P = 0.00) and EUS signiﬁ  cantly the highest: 
5.6 (2.6, range 3–14) (all P = 0.00). For PET, the average 
score for total burden was 4.6 (SD 2.2, range 3–14) and was 
comparable with US 4.2 (SD 2.0, range 3–12) (see Table 2, 
Figure 1). EUS causes the most burden for all dimensions 
and CT the least. US is more associated with anxiety than 
with embarrassment or discomfort.
In a subgroup analysis of patients with or without a FNA 
in US and EUS, there was a signiﬁ  cant higher perceived total 
burden for US with FNA (n = 14, mean 5.1, SD 2.2) versus 
US without FNA (n = 68, mean 4.0 SD 1.9) (P = 0.02), which Patient Preferences and Adherence 2008:2 160
Westerterp et al
was due to difference in perceived discomfort (1.7 versus 1.3, 
respectively; P = 0.004). There was no signiﬁ  cant difference 
in total perceived burden for EUS with (n = 8, mean 6.6 SD 
1.8) or without FNA (n = 74, mean 5.5 SD 2.7).
The 4’s and 5’s for the various tests and dimensions were 
distributed in one limited group of 3 patients (these 3 patients 
reported much burden from all tests on all dimensions) and a 
larger group of 12 patients who reported much burden from 
one test (EUS and CT).
Seventy-ﬁ  ve patients (91%) completed the ranking ques-
tion. Half of the patients double-ranked tests (eg, 2 tests were 
perceived as least inconvenient), which was corrected for. 
Table 2 Reported burden scores (1 ‘none’, 2 ‘little’, 3 ‘quite’, 4 ‘very’, and 5 ‘very much’) for anxiety, embarrassment, discomfort, and their 
total for all staging procedures
   Score          Average  SD  Signiﬁ  cance
    1 2 3 4  5     
US  anxiety  56 18 6  1 1  1.5  0.8 EUS p = 0.01  CT p = 0.00    PET p = 0.76
  embarrassment  60 14 5  1 2  1.4  0.9 EUS p = 0.00  CT p = 0.06    PET p = 0.24
  discomfort  62 14 3  3 0  1.4  0.7 EUS p = 0.00  CT p = 0.06    PET p = 0.01
  total         4.2  2.0  EUS p = 0.00  CT p = 0.00    PET p = 0.11
EUS  anxiety  47 20 9  1 4  1.7  1.0 US p = 0.01    CT p = 0.00    PET p = 0.03
  embarrassment  36 25 13 6 1  1.9  1.0 US p = 0.00    CT p = 0.00    PET p = 0.00
  discomfort  28 32 14 6 1  2.0  1.0 US p = 0.00    CT p = 0.00    PET p = 0.00
  total         5.6  2.6  US p = 0.00    CT p = 0.00    PET p = 0.00
CT  anxiety  71  8 1 1  1  1.2  0.6  US p = 0.00    EUS p = 0.00  PET p = 0.01
  embarrassment  62 16 3  1 0  1.3  0.6 US p = 0.06    EUS p = 0.00  PET p = 0.00
  discomfort  68 13 1  0 0  1.2  0.4 US p = 0.06    EUS p = 0.00  PET p = 0.00
  total         3.7  1.3  US p = 0.00    EUS p = 0.00  PET p = 0.00
PET  anxiety  63 11 2  3 3  1.4  1.0 US p = 0.76    EUS p = 0.03  CT p = 0.01
  embarrassment  53 19 7  1 2  1.5  0.9 US p = 0.24    EUS p = 0.00  CT p = 0.00
  discomfort  44 30 5  3 0  1.6  0.8 US p = 0.01    EUS p = 0.00  CT p = 0.00
  total         4.6  2.2  US p = 0.11    EUS p = 0.00  CT p = 0.00
Abbreviations: US, ultrasonography; EUS, endoscopic ultrasonography; CT, computed tomography; PET, positron emission tomography; SD, standard deviation.
Notes: Signiﬁ  cance of differences between the scores of the staging procedures are mentioned in the last column.
0.0 2.5 5.0 7.5 10.0
Total
Discomfort
Embarrasment
Anxiety
CT
US
EUS
PET
Figure 1 Burden scores of the four tests in the diagnostic work-up of patients with esophageal cancer with respect to anxiety, embarrassment, discomfort, and sum burden.
Notes: Values indicate mean and standard deviation (SD); n = 82.
Abbreviations: US, cervical ultrasonography; EUS, endoscopic ultrasonograhy; CT, computed tomography; PET, positron emission tomography.Patient Preferences and Adherence 2008:2 161
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US and CT were most often ranked as least inconvenient 
(64% and 60%, respectively, Figure 2). Patients perceived 
EUS as the most inconvenient test (46% of rankings). PET 
was mostly ranked in the middle of the spectrum of incon-
venience. Yet PET was reported 35% of rankings as least 
inconvenient and 16% as most inconvenient.
Discussion
To our knowledge this is the ﬁ  rst study to systematically 
investigate the patient burden of US, EUS, CT, and PET. 
This study shows that US, EUS, CT and PET are associ-
ated with low average levels of patient burden when used 
for the evaluation of esophageal carcinoma. Signiﬁ  cant 
but small differences in the absolute amount of perceived 
burden between the tests could be observed. The average 
burden scores between 1.0 and 2.0 indicate that all patients 
experienced a low burden for all tests, but the individual 
scores per test reveals that a substantial number of patients 
experienced a high or even very high burden for a particular 
test. Especially anxiety in case of PET and all 3 items in case 
of EUS should be noticed.
The invasiveness of EUS is often mentioned as a draw-
back of this procedure. This is reﬂ  ected in its relatively high 
burden scores for all items in this study. These values were 
still lower than anticipated, which might be explained by the 
availability of a thin scope and the application of sedation. 
Due to sedation the patient does not experience excessive 
burden of the investigation, and even forgets the experience, 
because of retrograde amnesia.
For PET a low average overall burden was observed 
(although some individual patients reported a high burden), 
which may be due to the context of diagnostic staging of a 
life threatening disease. Nevertheless, in our opinion, this 
issue will not hamper implementation of PET in the standard 
preoperative work-up of patient with esophageal cancer. In 
fact, PET is in general well accepted by the patients and 
adverse effects are rarely found. However, in this study CT 
is perceived even less uncomfortable than PET, probably 
due to the long room-time (especially scan-time) of PET 
compared with CT. Although, this item was not listed in the 
questionnaire, the long room-time of PET was often sponta-
neously reported by the patients as a drawback of the test. In 
the future, scanning time will be signiﬁ  cantly reduced by the 
fusion of the established technologies of PET and CT into a 
single PET/CT system. In addition, some patients reported 
to be anxious for radioactivity, despite proper information 
provided in advance. In case of CT, no serious side effects 
of administered contrast medium were reported in this study 
population, which may have contributed to the favorable 
scores for CT in this study. Claustrophobia was not reported 
or noticed in the present study population; nevertheless it 
is well-known that claustrophobia may seriously hamper 
diagnostic tests like CT or PET.
In the present study, a 2-week interval between test and 
questionnaire was chosen, because we assumed that experi-
ence and preference are preferably measured after a certain 
time because this may better reﬂ  ect future behavior than 
if experience and preference are measured under stressful 
circumstances. The study of van Gelder and colleagues 
(2004) showed that the experienced burden is the highest 
immediately after the tests. From then on, burden decreases. 
If a very long time period after testing should be chosen, it 
Figure 2 Inconvenience ranking of four tests in the diagnostic work-up of patients with esophageal carcinoma.
Notes: Grey bar: cervical ultrasonography; white bar: endosonography; black bar: computed tomography; striped bar: positron emission tomography.
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can be assumed that patients will forget the tests and burden 
could be underestimated. However it remains unknown 
when these opinions change and which interval should be 
used to optimally measure patient preference. Future studies 
will have to address the optimal time interval between the 
experience and evaluation.
A number of potential limitations of this study should be 
taken into account. Our study group consisted of patients with 
a life-threatening disease, and this may have inﬂ  uenced the 
relatively low degree to which they experience diagnostic 
procedures as a burden. In addition, the observed imbalance 
between men and women in the present study was not due 
to a form of selection bias but is inherent to the disease of 
esophageal carcinoma (Wijnhoven 2002). Further, an addi-
tional FNA was needed during US or EUS in some but not 
all patients. In a subanalysis there were higher perceived 
burden scores in the US-FNA subgroup, but not in de EUS-
FNA subgroup. Finally, we have tried to standardize the 
information given to patients by handing out, prior to test-
ing, a written information sheet. However we cannot claim 
that all patients received exactly the same oral information 
by their specialists.
In conclusion, signiﬁ  cant but small differences were 
observed in patient burden for imaging tests to evaluate 
esophageal carcinoma. The perceived burden of PET was 
lower than the perceived burden of EUS, but higher than 
the perceived burden of CT. As the average burden values 
were low for all tests, we ﬁ  nd it safe to conclude that the 
role of patient perception in the search for an optimal stag-
ing algorithm for esophageal cancer patients will be limited. 
The preferred diagnostic pathway will most likely be based 
on maximizing diagnostic accuracy.
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